Abstract

BackgroundCareStart™ malaria HRP2/pLDH (Pf/pan) combo test is one of the several rapid diagnostic tests (RDT) approved for diagnosis of malaria at the point of care in Tanzania. However, there are limited studies on the diagnostic performance of RDT after wide scale use in primary health care facilities in Tanzania. Therefore, this study was carried out to determine the diagnostic performance of RDT when compared with blood smear (BS) microscopy as a reference standard.MethodsA cross-sectional study was conducted between March and August 2019 at Kibiti Health Centre, Pwani region, Tanzania. Blood samples for malaria tests were collected from patients with malaria symptoms. Diagnostic performance parameters of RDT, i.e. sensitivity, specificity, positive and negative likelihood ratios (LR+/−), diagnostic accuracy and predictive values were determined using contingency table. An agreement between RDT and microscopy was statistically determined by Cohen’s kappa test.ResultsOf 980 patients screened, 567 (57.9%) were found to be malaria positive by RDT, whereas 510 patients (52%) were positive by microscopy. Of the 510 microscopy-positive patients, 487 (95.5%) were infected with Plasmodium falciparum. The geometric mean parasite density was 2921parasites/µl, whereas majority (68.6%) of patients had parasite density greater than 10,000/µl. The sensitivity, specificity, positive and negative predictive values of CareStart™ were 99.8%, 87.6%, 89.8%, and 99.8%, respectively. The LR+ and LR− were 8.0 and 0.002, respectively. The diagnostic accuracy was 0.5. There was a strong agreement between the results obtained using CareStart™ and BS microscopy (kappa = 0.863, P < 0.0001).ConclusionCareStart™ malaria HRP2/pLDH (Pf/pan) had high sensitivity and strong agreement with microscopy results. However, moderate specificity of RDT resulted in a substantial number of patients with false positive malaria test. Wherever available, microscopy should be used to confirm RDT test results.

Highlights

  • CareStartTM malaria HRP2/Plasmodium lactate dehydrogenase (pLDH) (Pf/pan) combo test is one of the several rapid diagnostic tests (RDT) approved for diagnosis of malaria at the point of care in Tanzania

  • A total of 980 patients, i.e. both CareStartTM malaria positive and negative individuals were subjected to blood smear (BS) microscopy

  • Of 980 patients, 567 (57.9%) were found to be malaria positive as determined by CareStartTM, while 413 patients were malaria negative. Both CareStartTM malaria positive and negative individuals were subjected to BS microscopy

Read more

Summary

Introduction

CareStartTM malaria HRP2/pLDH (Pf/pan) combo test is one of the several rapid diagnostic tests (RDT) approved for diagnosis of malaria at the point of care in Tanzania. There are limited studies on the diagnostic performance of RDT after wide scale use in primary health care facilities in Tanzania. In Tanzania, microscopy is still considered as a reference standard in malaria diagnosis at the point of care [3]. Routine use of microscopy for accurate diagnosis of malaria in the health facilities faces a number of challenges. These challenges include qualified human resources, stable electrical power supply, quality of blood slides, low parasite densities, and altered parasite morphology caused by chemoprophylaxis or empiric therapy [3,4,5,6]. The advantages of RDT include easy to use, provision of results from whole blood within 20 min, easy to carry diagnostic kits and require less skilled personnel [9, 10]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call